See the Complete Picture.
Published loading...Updated

Hong Kong healthcare investor looks for biotech’s ‘DeepSeek moment’ in China

Summary by South China Morning Post
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

South China Morning Post broke the news in Hong Kong on Saturday, May 17, 2025.
Sources are mostly out of (0)